AdvaMed on Inclusion of Device Tax Repeal in Funding Agreement: “Today Is a Great Day for American Patients” | AdvaMed

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement on the announcement by congressional leadership of a funding agreement that includes full repeal of the medical device excise tax. The agreement is expected to be passed this week by Congress and signed into law by President Trump:

Read the full article here

Related Articles